- Home
- LVTX vs MDBH Comparison
LVTX vs MDBH Comparison
Compare LVTX & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- MDBH
- Stock Information
- Founded
- LVTX 2016
- MDBH 1997
- Country
- LVTX Netherlands
- MDBH United States
- Employees
- LVTX N/A
- MDBH N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- MDBH
- Sector
- LVTX Health Care
- MDBH
- Exchange
- LVTX Nasdaq
- MDBH Nasdaq
- Market Cap
- LVTX 40.0M
- MDBH 35.1M
- IPO Year
- LVTX 2021
- MDBH 2023
- Fundamental
- Price
- LVTX $1.64
- MDBH $3.44
- Analyst Decision
- LVTX Hold
- MDBH
- Analyst Count
- LVTX 4
- MDBH 0
- Target Price
- LVTX $1.58
- MDBH N/A
- AVG Volume (30 Days)
- LVTX 131.8K
- MDBH 13.8K
- Earning Date
- LVTX 11-06-2025
- MDBH 11-13-2025
- Dividend Yield
- LVTX N/A
- MDBH N/A
- EPS Growth
- LVTX N/A
- MDBH N/A
- EPS
- LVTX N/A
- MDBH 0.76
- Revenue
- LVTX $4,990,000.00
- MDBH $1,250,398.00
- Revenue This Year
- LVTX N/A
- MDBH N/A
- Revenue Next Year
- LVTX N/A
- MDBH N/A
- P/E Ratio
- LVTX N/A
- MDBH $4.28
- Revenue Growth
- LVTX N/A
- MDBH N/A
- 52 Week Low
- LVTX $0.85
- MDBH $3.16
- 52 Week High
- LVTX $2.00
- MDBH $8.95
- Technical
- Relative Strength Index (RSI)
- LVTX 62.46
- MDBH 45.56
- Support Level
- LVTX $1.60
- MDBH $3.25
- Resistance Level
- LVTX $1.83
- MDBH $3.60
- Average True Range (ATR)
- LVTX 0.07
- MDBH 0.23
- MACD
- LVTX 0.01
- MDBH -0.01
- Stochastic Oscillator
- LVTX 65.28
- MDBH 38.14
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.